DIA 2023 Global Annual Meeting
Meet the Medable team at this year's DIA. Hosted in Boston, DIA 2023 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.
WCG Avoca Quality Consortium Summit
Medable's CSO, Pam Tenaerts, PhD will participate in the executive panel: From Knowledge to Wisdom.
Digital Health Innovation Summit
Join us for a unique opportunity to connect with industry leaders and learn about the latest in clinical trial innovation.
London Tech Week
Catch Michelle Longmire on the Leaders Stage - HealthTech Summit for a riveting Panel Discussion: The World’s Most Interesting Trials.
Ethical review of Decentralized Clinical Trials (DCTs): Tools, resources & best practices
Barbara Bierer (MRCT Center), Pam Tenaerts (Medable) and Leanne Madre (Medable) will present a framework, recommendations, and tools organized around 3 DCT domains: People, Remote Data Collection, and Data Oversight. Best practices for the ethical review, approval, and conduct of DCTs will be provided.
DCT Digital Week: Creating the Digital Foundation for Scale in Clinical Development
Learn how sponsors and CROs can improve their clinical trial conduct by developing new strategies that create sustainable, repeatable, and effective clinical conduct.
eCOA Digital Week: An honest assessment of eCOAs from a site perspective
Joe Dustin, VP/GM of eCOA and Annie Hesslewood, Site & Patient adoption lead at Medable host an open discussion with a panel of sites and CRAs to provide a candid assessment of how upcoming changes in the eCOA landscape can reduce burden on participants and sites to maximize the chance of success in clinical trials.
Leverage novel options in oncology clinical trial design to reduce burden for patients and sites
Flo Mowlem, Senior Director, eCOA Science & Solutions shares insights on how electronic solutions, with a focus on patient-reported outcome (ePROs) can reduce burden on participants and sites to maximize the chance of success in oncology clinical trials.